A Comparison of Premixed and Basal-Bolus Insulin Intensification Therapies in Patients With Type 2 Diabetes Mellitus With Inadequate Glycaemic Control on Twice-daily Premixed Insulin.
Phase of Trial: Phase IV
Latest Information Update: 17 Dec 2013
At a glance
- Drugs Insulin glargine (Primary) ; Insulin lispro (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 10 Jun 2017 Biomarkers information updated
- 01 Nov 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Jun 2012 Planned end date changed from 1 Jan 2013 to 1 Nov 2012 as reported by ClinicalTrials.gov.